[Federal Register Volume 62, Number 5 (Wednesday, January 8, 1997)] [Notices] [Page 1134] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 97-430] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 15, 1996, Orpharm, Inc., 728 West 19th Street, Houston, Texas 77008, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basis classes of controlled substances listed below: ------------------------------------------------------------------------ Drug Schedule ------------------------------------------------------------------------ Methadone (9250)............................ II Methadone-intermediate (9254)............... II Levo-alphacetylmethadol (LAAM) (9648)....... II ------------------------------------------------------------------------ The firm plans to manufacture methadone and methadone-intermediate for the production of LAAM. Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application. Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, D.C. 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than March 10, 1997. Dated: December 17, 1996. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 97-430 Filed 1-17-97; 8:45 am] BILLING CODE 4410-09-M